Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Awakn Life Sciences logo — Therapeutics for substance use and mental health disorders

Awakn Life Sciences

Therapeutics for substance use and mental health disorders

Founded 2020 Canada Toronto, Canada 10 employees Post-IPO Equity Total: $13.67M Biotechnology, Health Care +1

General Information

Company Name Awakn Life Sciences
Founded Year 2020
Location Canada Toronto, Canada
Employees 10
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Awakn Life Sciences. To contact Awakn Life Sciences, visit awaknlifesciences.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Awakn Life Sciences compare?

A PDF of Awakn Life Sciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Awakn Life Sciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Awakn Life Sciences

Awakn Life Sciences is a clinical-stage biotechnology company focused on developing medication-assisted treatments for addiction. With a near-term focus on Alcohol Use Disorder (AUD), the company aims to address the inadequacies of current standard treatments for the condition, which affects approximately 51 million people in the US and key European markets and 285 million people globally. Founded in 2020, Awakn Life Sciences aims to provide breakthrough therapeutics to addiction sufferers and commercialize its R&D pipeline across multiple channels. The company's revolutionary approach to treating addiction positions it within the biotechnology and healthcare industries. Additionally, the recent $131.43KPost-IPO Equity investment at 03 February 2024 underlines investor confidence in Awakn's mission and potential impact. As the company continues to advance its innovative treatments, it presents an intriguing opportunity for venture capitalists seeking meaningful investments in the biotechnology and healthcare sectors.

Business keywords: Clinical-stage, Medication-assisted treatments, Addiction, Alcohol Use Disorder, Breakthrough therapeutics, R&D pipeline, Commercialization, Pharmaceuticals, Drug development, Mental health, Treatment innovation

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $131.43K -
03 Feb 2024
Post IPO Equity $1.97M 1
Mystic Ventures
Mystic Ventures
26 Apr 2023
Post IPO Debt $775.00K 1
TD Veen
TD Veen
25 Oct 2022
Grant $2.50M 1
National Institute for Health Research
20 Jul 2022
Grant Undisclosed 1
Innovate UK
Innovate UK
18 Jul 2022
Funding Round $8.30M 1
Negev Capital
Negev Capital
08 Jun 2021

Awakn Life Sciences Alternatives & Competitors

View All Alternatives
Awakn Life Sciences vs
Proniras Corporation
Proniras Corporation United States

Clinical-stage biotechnology developing therapeutics for the treatment of substance use & specialty...

Series B
4 employees
Biotechnology, Health Care
Awakn Life Sciences vs
Arcade Therapeutics
Arcade Therapeutics United States

We make therapeutic games for mental well-being, supported by rigorous evidence.

Seed
10 employees
Digital Health, Health Care
Awakn Life Sciences vs
BioCorRx Pharmaceuticals Inc.
BioCorRx Pharmaceuticals Inc. United States

BioCorRx Pharmaceuticals is focused on the development of addiction treatments and related disorders...

Grant
2 employees
Biotechnology, Health Care
View all alternatives

FAQ About Awakn Life Sciences

Therapeutics for substance use and mental health disorders
Awakn Life Sciences was founded in 2020.
Awakn Life Sciences is headquartered in Toronto, Canada.
Awakn Life Sciences operates in Biotechnology, Health Care and Life Sciences. Its work centres on Clinical-stage, Medication-assisted treatments, Addiction and Alcohol Use Disorder.
Awakn Life Sciences has approximately 10 employees.
Awakn Life Sciences has completed 6 funding rounds, raising a total of $13.67M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Awakn Life Sciences include Proniras Corporation, Arcade Therapeutics, BioCorRx Pharmaceuticals Inc., Adial Pharmaceuticals, Orexo AB publ. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Awakn Life Sciences and Proniras Corporation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Awakn Life Sciences, https://bouncewatch.com/company/awakn-life-sciences, updated 2 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout